slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
197,221-197,280 of 319,975
21
Absci | Investor Conference Presentation Deck | 21 slidesAbsci | Investor Conference Presentation Deck | 21 slides · absci
Conference presentation Investor relations Beat · Action1 hit
01
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Attention1 hit
02
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Attention1 hit
03
The slide uses a hub-and-spoke diagram to represent the company's business model.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a hub-and-spoke diagram to show the core business (Alkermes) and its various value drivers, with a separate node for the proposed Oncology Company spin-off.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
05
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
06
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
07
Includes a boxed warning disclaimer at the bottom.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
08
The chart shows a steady upward trend in total prescriptions (TRx) over 61 weeks, with a notable dip around week 58.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
09
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
10
The slide uses a combination of a treatment matrix and a donut chart to align product labeling with real-world patient needs.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
11
The slide includes a disclaimer regarding the boxed warning for the drug.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
12
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
13
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
14
The slide uses a medical illustration of the brain to show neurotransmitter pathways.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
15
Includes a molecular structure visualization of the Orexin 2 receptor.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
16
The slide presents preclinical efficacy data for RDC-264177 using a DTA mouse model.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
17
The slide uses PharmacoEEG heatmaps to visualize brain activity frequency over time.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
18
The slide uses a process flow diagram to illustrate the progression from Single Ascending Dose to Multiple Ascending Dose and Proof-of-Concept studies.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
19
The slide uses a side-by-side comparison layout to delineate two distinct clinical trial phases.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
20
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
21
The slide outlines the core assets (nemvaleukin alfa, IL-12, IL-18) and the strategic rationale for a spin-off.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
22
The slide uses a human body diagram to map clinical responses (CR, PR, uPR) by tumor type.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
23
The slide uses a 2x2 matrix-like layout to categorize studies by 'Potential Registration Enabling Studies' and 'Alternative Dosing Studies'.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
24
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
25
The slide outlines the strategic rationale for a corporate spin-off, focusing on the remaining neuroscience-focused entity.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
26
The chart tracks revenue for VIVITROL, ARISTADA, VUMERITY, and LYBALVI.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
27
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
28
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
01
Amazon | Results Presentation Deck | 19 slidesAmazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
02
Amazon | Results Presentation Deck | 19 slidesAmazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations 1 hit
03
The bar chart includes a callout indicating 9% Y/Y growth and 12% F/X adjusted growth.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Mece Breakdown1 hit
04
The slide uses a trailing twelve-month (TTM) metric to smooth out seasonal fluctuations in sales.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Mece Breakdown1 hit
05
The chart includes a callout box specifying the percentage decline in operating income.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Mece Breakdown1 hit
06
The chart highlights a 51% year-over-year decline in operating income.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Mece Breakdown1 hit
07
The slide includes a footnote explaining the impact of Rivian Automotive investment valuation changes on net income.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Mece Breakdown1 hit
08
The slide includes a footnote explaining that the Q4 2022 net loss was significantly impacted by a valuation loss on a Rivian Automotive investment.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Mece Breakdown1 hit
09
The slide uses two bar charts to show financial performance trends.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
10
TTM figures provided at the bottom.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
11
TTM figures provided at the bottom.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What Is1 hit
12
The chart uses a waterfall-style layout for negative values, though it is technically a bar chart.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Cost Of Inaction1 hit
13
The chart displays negative values for all periods, indicating cash outflows.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Cost Of Inaction1 hit
14
The chart displays negative values (outflows) for all periods shown.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · What IsLoop · Cost Of Inaction1 hit
15
The chart highlights the stability of share counts over time, supporting the goal of managing dilution.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
16
Amazon | Results Presentation Deck | 19 slidesAmazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
17
The table displays financial data in millions (MM).Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
18
The table displays TTM (Trailing Twelve Months) data points for five consecutive quarters from Q4 2021 to Q4 2022.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
19
The table provides a detailed breakdown of cash flow adjustments for finance leases and financing obligations.Amazon | Results Presentation Deck | 19 slides · Amazon
Conference presentation Investor relations Beat · New Bliss1 hit
01
argenx SE | Investor Conference Presentation Deck | 22 slidesargenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Is1 hit
02
argenx SE | Investor Conference Presentation Deck | 22 slidesargenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Is1 hit
03
argenx SE | Investor Conference Presentation Deck | 22 slidesargenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Is1 hit
04
The slide uses a circular graphic to emphasize the 'revolution' in autoimmunity.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What IsLoop · Aha Moment1 hit
05
The slide uses a circular graphic featuring patient photos to emphasize the human-centric approach.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What IsLoop · Golden Circle1 hit
06
The slide uses a four-circle cluster diagram to represent strategic pillars.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Is1 hit
07
The slide uses a bar chart to show quarterly revenue growth and callout boxes to highlight operational and market access milestones.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Is1 hit
08
The slide uses two line charts to show efficacy metrics (IgG reduction and platelet count) and lists four medical/scientific publication sources at the bottom.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
09
Includes a 3-step mechanism of action diagram.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
10
The diagram uses a four-circle overlapping layout to represent strategic pillars.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
11
The slide uses a hub-and-spoke style diagram to organize strategic pillars.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
12
The slide uses a hub-and-spoke visual metaphor to connect the clinical class of medicines to a list of specific autoantibody targets.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit